期刊文献+

采用Viatorr支架行TIPS治疗门静脉高压症疗效 被引量:10

Efficacy of Viatorr TIPS in treating portal hypertension
下载PDF
导出
摘要 目的分析Viatorr支架用于TIPS治疗门静脉高压的临床疗效。方法收集使用Viatorr支架行TIPS治疗的34例门静脉高压患者,分析术后门静脉压力下降情况、肝性脑病发病率及分流道通畅率。结果采用Viatorr支架行TIPS技术成功率100%;术前、术后门静脉压力分别为(40.00±3.85)cmH_2O和(23.60±2.87)cmH_2O。术后随访1~14个月,分流道通畅率100%(34/34),肝性脑病发病率5.88%(2/34)。结论使用Viatorr支架行TIPS治疗门静脉高压手术操作成功率高,分流道通畅率高,术后肝性脑病发生率低。 Objective To observe clinical effect of Viatorr stents in TIPS for treatment of portal hypertension.Methods Thirty-four portal hypertension patients who underwent TIPS using Viatorr stents were collected.The portal vein pressure,the incidence of hepatic encephalopathy and patency rate of shunt were analyzed.Results TIPS was successfully performed using Viatorr stent,the technical success rate was 100%.The preoperative and postoperative portal pressures were(40.00±3.85)cmH2O and(23.60±2.87)cmH2O,respectively.During 1 to 14 months'follow-up,the patency rate of shunt was 100%(34/34),and the incidence of hepatic encephalopathy was 5.88%(2/34).Conclusion Viatorr TIPS for treatment of portal hypertension has high operative success rate,high shunt patency rate and low incidence of hepatic encephalopathy.
作者 鲍应军 顾俊鹏 张海潇 朱帝文 任伟新 BAO Yingjun;GU Junpeng;ZHANG Haixiao;ZHU Diwen;REN Weixin(Department of Interventional Radiology,the First Teaching Hospital of Xinjiang Medical University,Urumqi 830054,China)
出处 《中国介入影像与治疗学》 北大核心 2019年第1期12-15,共4页 Chinese Journal of Interventional Imaging and Therapy
关键词 高血压 门静脉 Viatorr支架 门体静脉分流术 经颈静脉肝内 hypertension,portal Viatorr stent portosystemic shunt,transjugular intrahepatic
  • 相关文献

参考文献8

二级参考文献56

  • 1Jin-Hua Zeng, Zhen Yang, Jun Xu, Ming-Lian Qiu and Ke-Can Lin Department of Surgery, First Affiliated Hospital of Fu-jian Medical University, Fuzhou 350004 , China Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.Down-regulation of the gax gene in smooth muscle cells of the splenic vein of portal hypertension patients[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):242-245. 被引量:4
  • 2Liang Shuo Hu,Jacob George,Jian Hua Wang.Current concepts on the role of nitric oxide in portal hypertension[J].World Journal of Gastroenterology,2013,19(11):1707-1717. 被引量:18
  • 3<中华放射学杂志>编委会介入组.经颈静脉肝内门体静脉分流术临床技术指南[J].中华放射学杂志,2004,38(12):1329-1332. 被引量:41
  • 4Maleux G, Nevens F, Wilmer A, et al. Early and long-term clini- cal and radiological follow-up results of expanded-polytetrafluoro- ethylene-covered stent-grafts for transjugular intrahepatic porto- systemic shunt procedures. Eur Radiol, 2004, 14 (10) : 1842- 1850.
  • 5Hausegger KA, Karnel F, Georgieva B, et al. Transjugular in- trahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol, 2004,15(3) :239-248.
  • 6Gareia-Pag6n JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med, 2010,362(25) :2370-2379.
  • 7Boyer TD, Haskal ZJ. American association for the study of liver diseases. Hepatology, 2001,34(4) :A2-A5.
  • 8Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopa- thy definition, nomenclature, diagnosis, and quantification: Final report of the working party at the llth Word Congresses of gas- troenterology, Vienna, 1998. Hepatology, 2002, 35(3):716- 721.
  • 9Bai M, Qi X, Yang Z, et al. Predictors of hepatic eneephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic pa- tients: A systematic review. J Gastroenterol Hepatol, 2011,26 (6) :943-951.
  • 10Rossi P, Salvatori FM, Fanelli F, et al. Polytetrafluoroethyl- ene-covered nitinol stent-graft for transjugular intrahepatic port- osystemic shunt creation: 3-year experience. Radiology, 2004, 231(3) :820-830.

共引文献55

同被引文献60

引证文献10

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部